Progressive endothelial cell damage in an inflammatory model of pulmonary hypertension

REFERENCES

• Dorfmuller P, Perros F, Balabanian K, Humbert M: Inflammation in pulmonary arterial hypertension. Eur Respir J. 2003;22:358–363.
   PubMed Web of Science ®Google Scholar
• Gurubhagavatula I, Palevsky HI: Pulmonary hypertension in systemic autoimmune disease. Rheum Dis Clin N Am. 1997;23:365–394.
   PubMed Web of Science ®Google Scholar
• Humbert M, Monti G, Brenot F, Sitbon O, Portier A, Grangeot-Keros L, Duroux P, Galanaud P, Simonneau G, Emilie D: Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med. 1995;151:1628–1631.
   PubMed Web of Science ®Google Scholar
• Bhargava A, Kumar A, Yuan N, Gewitz MH, Mathew R: Monocrotaline induces interleukin-6 mRNA expression in rat lungs. Heart Dis. 1999;1:126–132.
   Google Scholar
• Miyata M, Sakuma F, Yoshimura A, Ishikawa H, Nishimaki T, Kasukawa R: Pulmonary hypertension in rats. 2. Role of interleukin-6. Int Arch Allergy Immunol. 1995;108:287–291.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Schlegel A, Scherer PE, Lisanti MP: Caveolins, a family of scaffolding proteins for organizing “preassembled signaling complexes” at the plasma membrane. J Biol Chem. 1998;273:5419–5422.
   PubMed Web of Science ®Google Scholar
• Garrean S, Gao XP, Broykovych V, Shimizu J, Zhao YY, Vogel SM, Malik AB: Caeolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J Immunol. 2006;177:4853–4860.
   PubMed Web of Science ®Google Scholar
• Mathew R, Huang J, Shah M, Patel K, Gewitz M, Sehgal PB: Disruption of endothelial-cell caveolin-1α/raft scaffolding during development of monocrotaline-induced pulmonary hypertension. Circulation. 2004;110:1499–1506.
   PubMed Web of Science ®Google Scholar
• Lévy M, Maurey C, Celermajer DS, Vouhé PR, Danel C, Bonnet D, Israël-Biet D: Impaired apoptosis of pulmonary endothelial cells is associated with intimal proliferation and irreversibility of pulmonary hypertension in congenital heart disease. J Am Coll Cardiol. 2007 49:803–810.
   PubMed Web of Science ®Google Scholar
• McMurtry MS, Archer SL, Altieri DC, Bonnet S, Haromy A, Harry G, Bonnet S, Puttagunta L, Michelakis ED: Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension. J Clin Invest. 2005;115:1461–1463.
   PubMedGoogle Scholar
• Heinrich PC, Behrmann I, Haan S, Hermanns HM, Müller-Newen G, Schaper F: Principles of interleukin (IL)-6-type cytokine signaling and its regulation. Biochem J. 2003;374:1–20.
   PubMed Web of Science ®Google Scholar
• Podar K, Tai YT, Cole CE, Hideshima T, Sattler M, Hamblin A, Mitsiades N, Schlossman RL, Davies FE, Morgan GJ, Munshi NC, Chauhan D, Anderson KC: Essential role of caveolae in interleukin-6 and insulin like growth factor 1-trggered Akt-1 mediated survival of multiple myeloma cells. J Biol Chem. 2003;278:5794–5801.
   PubMed Web of Science ®Google Scholar
• Celermajer DS, Cullen S, Deanfield JE: Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation. 1993;87:440–446.
   PubMed Web of Science ®Google Scholar
• Dinh-Xuan AT, Higenbottam TW, Clelland C, Pepke-Zaba J, Cremona G, Wallwork J: Impairment of pulmonary endothelium-dependent relaxation in patients with Eisenmenger's syndrome. Br J Pharmacol. 1990;99:9–10.
   PubMed Web of Science ®Google Scholar
• Mathew R, Zeballos GA, Tun H, Gewitz MH: Role of nitric oxide and endothelin 1 in monocrotaline-induced pulmonary hypertension in rats. Cardiovasc Res. 1995;30:739–746.
   PubMed Web of Science ®Google Scholar
• Liu J, Garcia-Cardena G, Sessa WC: Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry. 1996;35:13277–13281.
   PubMed Web of Science ®Google Scholar
• Sonveaux P, Martinive P, DeWever J, Batova Z, Daneau G, Pelat M, Ghisdal P, Grégoire V, Dessy C, Balligand JL, Feron O: Caveolin-1 expression is critical for vascular endothelial growth factor-induced ischemic hindlimb collateralization and nitric oxide-mediated angiogenesis. Circ Res. 2004;95:154–161.
   PubMed Web of Science ®Google Scholar
• Darblade B, Caillaud D, Poirot M, Fouque M, Thiers JC, Rami J, Bayard F, Arnal JF: Alteration of plasmalemmal caveolae mimics endothelial dysfunction observed in atheromatous rabbit aorta. Cardiovasc Res. 2001;50:566–576.
   PubMed Web of Science ®Google Scholar
• Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM: Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601–605.
   PubMed Web of Science ®Google Scholar
• Garcia-Cardena G, Fan R, Shah V, Sorrentino R, Cirino G, Papapetropoulos A, Sessa WC: Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature. 1998;392:821–824.
   PubMed Web of Science ®Google Scholar
• Takahashi S, Mendelsohn ME: Synergistic activation of endothelial nitric oxide synthase (eNOS) by HSP90 and Akt: calcium-independent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex. J Biol Chem. 2003;278:30821–30827.
   PubMed Web of Science ®Google Scholar
• Linder AE, McCluskey LP, Cole KR 3rd, Lanning KM, Webb RC: Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta. J Pharmacol Exp Ther. 2005;314:9–15.
   PubMed Web of Science ®Google Scholar
• Henriques-Coelho T, Oliveira SM, Moura RS, Roncon-Albuquerque R Jr, Neves AL, Santos M, Nogueira-Silva C, La Fuente carvalho F, Brandão-Nogueira A, Correia-Pinto J, Leite-Moreira AF: Thymulin inhibits monocrotaline-induced pulmonary hypertension modulating interleukin-6 expression and suppressing p38 pathway. Endocrinology. 2008;149:4367–4373.
   PubMed Web of Science ®Google Scholar
• Ito T, Okada T, Miyashita H, Nomoto T, Nonake-Sarukawa M, Uchibori R, Maeda Y, Urabe M, Mizukami H, Kume A, Takahashi M, Ikeda U, Shimada K, Ozawa K: Interleukin-10 expression mediated by an adeno-associated virus vector prevents monocrotaline-induced pulmonary arterial hypertension in rats. Circ Res. 2007;101:734–741.
   PubMed Web of Science ®Google Scholar
• Huang J, Kaminski PM, Edwards JG, Yeh A, Wolin MS, Frishman WH, Gewitz MH, Mathew R: Pyrrolidine dithiocarbamate restores endothelial cell membrane integrity and attenuates monocrotaline-induced pulmonary artery hypertension. Am J Physiol. 2008;294:L1250–L1259.
   PubMed Web of Science ®Google Scholar
• McMurtry MS, Bonnet S, Michelakis ED, Bonnet S, Haromy A, Archer SL: Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamycin-atorvastatin-simvastatin study. Am J Physiol. 2007;293:L933–L940.
   Web of Science ®Google Scholar
• Achcar RO, Demura Y, Rai PR, Taraseviciene-Stewart L, Kasper M, Voelkel NF, Cool CD: Loss of caveolin-1 and heme oxygenase expression in severe pulmonary hypertension. Chest. 2006;129:696–705.
   PubMed Web of Science ®Google Scholar
• Jasmin JF, Mercier I, Hnasko R, Cheung MW, Tanowitz HB, Dupuis J, Lisanti MP: Lung remodeling and pulmonary hypertension after myocardial infarction: pathogenic role of reduced caveolin expression. Cardiovasc Res. 2004;63:747–755.
   PubMed Web of Science ®Google Scholar
• Zhao YY, Liu Y, Stan RV, Fan L, Gu Y, Dalton N, Chu PH, Peterson K, Ross J Jr, Chien K: Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Proc Natl Acad Sci U S A. 2002;99:11375– 11380.
   PubMed Web of Science ®Google Scholar
• Torres VA, Tapia JC, Rodríguez DA, Párraga M, Lisboa P, Montoya M, Leyton L, Quest AF: Caveolin-1 controls cell proliferation and cell death by suppressing expression of the inhibitor of apoptosis protein survivin. J Cell Sci. 2006;119:1812–1823.
   PubMed Web of Science ®Google Scholar
• Jenkins BJ, Roberts AW, Najdovska M, Grail D, Ernst M: The threshold of gp130-dependent STAT3 signaling is critical for normal regulation of hematopoiesis. Blood. 2005;105:3512–3520.
   PubMed Web of Science ®Google Scholar
• Bromberg J: Stat proteins and oncogenesis. J Clin Invest. 2002;109:1139–1142.
   PubMed Web of Science ®Google Scholar
• Yu H, Jove R: The STATs of cancer—new molecular targets come of age. Nat Rev Cancer. 2004;4:97–105.
   PubMed Web of Science ®Google Scholar
• Mathew R, Huang J, Gewitz MH: Pulmonary artery hypertension: caveolin-1 and eNOS interrelationship: a new perspective. Cardiol Rev. 2007;15:143–149.
   PubMedGoogle Scholar
• Jasmin JF, Mercier I, Dupuis J, Tanowitz HB, Lisanti MP: Short-term administration of a cell-permeable caveolin-1 peptide prevents the development of monocrotaline-induced pulmonary hypertension and right ventricular hypertrophy. Circulation. 2006;114:912–920.
   Google Scholar
• Jasmin JF, Mercier I, Sotgia F, Lisanti MP: SOCS proteins and caveolin-1 as negative regulators of endocrine signaling. Trends Endocrin Metab. 2006;17:150–158.
   PubMed Web of Science ®Google Scholar
• Masri FA, Xu W, Comhair SA, Asosingh K, Koo M, Vasanji A, Drazba J, Anand-Apte B, Erzurum SC: Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol. 2007;293:L548–L554.
   PubMed Web of Science ®Google Scholar
• McLoughlin RM, Jenkins BJ, Grail D, Williams AS, Fielding CA, Parker CR, Ernst M, Topley N, Jones SA: IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc Natl Acad Sci U S A. 2005;102:9589–9594.
   PubMed Web of Science ®Google Scholar
• Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE Jr: STAT3 as an oncogene. Cell. 1999;98:295–303.
   PubMed Web of Science ®Google Scholar
• Pollman MJ, Hall JL, Mann MJ, Zhang L, Gibbons GH: Inhibition of neointimal cell bcl-xl expression induces apoptosis and regression of vascular disease. Nat Med. 1998;4:222–227.
   PubMed Web of Science ®Google Scholar
• Ni CW, Hsieh HJ, Chao YJ, Wang DL: Interleukin-6-induced JAK2/STAT3 signaling pathway in endothelial cells is suppressed by hemodynamic flow. Am J Physiol. 2004;287:C771–C780.
   Web of Science ®Google Scholar
• Mathew R, Gloster ES, Sundararajan T, Thompson CI, Zeballos GA, Gewitz MH: Role of inhibition of nitric oxide production in monocrotaline-induced pulmonary hypertension. J Appl Physiol. 1997;82:1493–1498.
   PubMed Web of Science ®Google Scholar
• Mathew R, Yuan N, Rosenfeld L, Gewitz MH, Kumar A: Effects of monocrotaline on endothelial nitric oxide synthase expression and sulfhydryl levels in rat lungs. Heart Dis. 2002;4:152–158.
   PubMedGoogle Scholar
• Zabel U, Kleinschnitz C, Oh P, Nedvetsky P, Smolenski A, Müller H, Kronich P, Kugler P, Walter U, Schnitzer JE, Schmidt HH: Calcium-dependent membrane association sensitizes soluble guanylyl cyclase to nitric oxide. Nat Cell Biol. 2002;4:307–311.
   PubMed Web of Science ®Google Scholar
• Nedvetsky PI, Meurer S, Opitz N, Nedvetskaya TY, Müller H, Schmidt HH: Heat shock protein 90 regulates stabilization rather than activation of soluble guanylate cyclase. FEBS Lett. 2008;582:327–331.
   PubMed Web of Science ®Google Scholar
• Venema RC, Venema VJ, Ju H, Harris MB, Snead C, Jilling T, Dimitropoulou C, Maragoudakis ME, Catravas JD: Novel complexes of guanylate cyclase with heat shock protein 90 and nitric oxide synthase. Am J Physiol. 2003;285:H669-H678.
   Web of Science ®Google Scholar
• Mathew R, Guzowski DE, Gloster ES: Effects of verapamil on monocrotaline-induced pulmonary artery hypertension and endothelial cell dysfunction in rats. Exp Lung Res. 1990;16:627–644.
   PubMed Web of Science ®Google Scholar
• Ye C, Rabinovitch M: Inhibition of elastolysis by SC-37698 reduces development and progression of monocrotaline pulmonary hypertension. Am J Physiol. 1991;261:H1255–H1267.
   PubMed Web of Science ®Google Scholar
• Smadja DM, Gaussem P, Mauge L, Israël-Beit D, Dignat-George F, Peyard S, Agnoletti G, Vouhé PR, Bonnet D, Lévy M: Circulating endothelial cells: a new candidate biomarker of irreversible pulmonary hypertension secondary to congenital heart disease. Circulation. 2009;119:374–381.
   PubMed Web of Science ®Google Scholar
• Sakao S, Taraseviciene-Stewart L, Wood K, Cool CD, Voelkel NF: Apoptosis of pulmonary microvascular endothelial cells stimulates vascular smooth muscle cell growth. Am J Physiol. 2006;291:L362–L388.
   Web of Science ®Google Scholar